All In Biotech

Drug Trial Radar · NCT00463866

Local Phase 4 Pan-European SMART Study

Last checked: Nov 19, 2026Latest source record: Mar 22, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 8,424 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

8,424

Actual

Start

Mar 2007

Primary completion

Not stated

Study completion Dec 2008

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Apr 20, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effect of two different maintenance doses of Symbicort Maintenance And Reliever Therapy (SMART) in adult asthmatic patients. A 6 month treatment period

Conditions

  • Asthma

Interventions

  • Budesonide/formoterolDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Severe Asthma Exacerbations Per Participant.Time frame: 6 months

Locations

817 sites in 14 countries. Site status is shown where the registry gives one.

  • Research Site

    Aalst, Belgium

  • Research Site

    Aarschot, Belgium

  • Research Site

    Aatrijken, Belgium

  • Research Site

    Asse, Belgium

  • Research Site

    Balen, Belgium

  • Research Site

    Bastogne, Belgium

  • Research Site

    Bellaire, Belgium

  • Research Site

    Betrix, Belgium

  • Research Site

    Binche, Belgium

  • Research Site

    Blankenberge, Belgium

  • Research Site

    Boortmeerbeek, Belgium

  • Research Site

    Bornem, Belgium

  • Research Site

    Boussu, Belgium

  • Research Site

    Bruges, Belgium

  • Research Site

    Brussels, Belgium

  • Research Site

    Buizingen, Belgium

  • Research Site

    Burdinne, Belgium

  • Research Site

    Champion, Belgium

  • Research Site

    Charleroi, Belgium

  • Research Site

    Châtelet, Belgium

  • Research Site

    Chênée, Belgium

  • Research Site

    Dendermonde, Belgium

  • Research Site

    Diksmuide, Belgium

  • Research Site

    Drongen, Belgium

  • Research Site

    Duffel, Belgium

  • Research Site

    Edegem, Belgium

  • Research Site

    Eeklo, Belgium

  • Research Site

    Ekeren, Belgium

  • Research Site

    Erembodegem, Belgium

  • Research Site

    Evergem, Belgium

  • Research Site

    Fleurus, Belgium

  • Research Site

    Gembloux, Belgium

  • Research Site

    Genk, Belgium

  • Research Site

    Ghent, Belgium

  • Research Site

    Gilly, Belgium

  • Research Site

    Graty, Belgium

  • Research Site

    Grivegnée, Belgium

  • Research Site

    Halle, Belgium

  • Research Site

    Ham, Belgium

  • Research Site

    Ham-sur-Heure, Belgium

Showing 40 of 817 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.